Does low vitamin D reduce bone mineral density?

Low vitamin D status contributes to reduced bone mineral density (BMD) through two distinct physiological pathways: impairing active intestinal calcium absorption and directly disrupting bone mineralization.

Clinical evidence and bone density outcomes

• Reduced calcium availability: Impaired calcium absorption directly reduces systemic calcium levels, triggering a compensatory rise in parathyroid hormone (PTH) to maintain calcium homeostasis.
• Secondary hyperparathyroidism and bone resorption: This chronic elevation of PTH (secondary hyperparathyroidism) stimulates osteoclast activity, driving calcium mobilization from the skeleton and leading to bone resorption and reduced BMD.
• Clinical prevalence: Large observational and clinical studies consistently link low serum 25-hydroxyvitamin D [25(OH)D] levels—typically defined as <20 ng/mL (50 nmol/L)—with accelerated bone loss and lower bone mineral density at the spine, hip, and femoral neck.

Molecular and mechanistic pathways

• Impaired active intestinal transport: Active vitamin D, 1,25-dihydroxyvitamin D [1,25(OH)2D], binds to the enterocyte vitamin D receptor (VDR). This upregulates the expression of key calcium transport proteins, including the apical calcium channel TRPV6, intracellular transport protein calbindin-D9k, and basolateral calcium pump PMCA1b. In vitamin D deficiency, this active transcellular transport pathway is severely impaired, reducing net intestinal calcium absorption.
• Disrupted matrix mineralization: Deficient vitamin D status decreases the absorption of both calcium and phosphate, reducing the systemic calcium-phosphate product below the threshold necessary for hydroxyapatite crystal formation and deposition in the organic osteoid matrix.
• Osteoid accumulation: This mineralization failure leads to a prolonged mineralization lag time and an accumulation of unmineralized osteoid, a defining histomorphometric feature of osteomalacia that directly contributes to reduced bone density and compromised skeletal strength.

Bottom line

Low vitamin D status reduces bone mineral density by impairing VDR-mediated active intestinal calcium absorption (which triggers secondary hyperparathyroidism and bone resorption) and by disrupting hydroxyapatite deposition, leading to defective bone matrix mineralization. Maintaining optimal vitamin D levels is critical to support these twin pathways and preserve bone density.